Furo[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents
Furopyrimidines are fused heterocyclic ring systems. Structurally, they are bioisoteres to purines and exerting pharmacological actions in various aspects. They are known to play an important role in different disease conditions. Furo[2,3-d]pyrimidines derivatives have been explored for their inhibi...
Main Authors: | Marwa A. Aziz, Rabah A.T. Serya, Deena S. Lasheen, Khaled A.M. Abouzid |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2016-06-01
|
Series: | Future Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2314724515300327 |
Similar Items
-
Thieno[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents
by: Eman Z. Elrazaz, et al.
Published: (2015-12-01) -
Design and effective synthesis of novel furo[2,3-d]pyrimidine derivatives containing ethylene ether spacers
by: Enayatollah Sheikhhosseini
Published: (2018-03-01) -
Pyrazolo[3,4-d]pyrimidine based scaffold derivatives targeting kinases as anticancer agents
by: Nasser S.M. Ismail, et al.
Published: (2016-06-01) -
Synthesis, Antitumor Activity, and Docking Analysis of New Pyrido[3′,2′:4,5]furo(thieno)[3,2-<i>d</i>]pyrimidin-8-amines
by: Samvel N. Sirakanyan, et al.
Published: (2019-10-01) -
Novel pyrrolo[2,3-d]pyrimidine derivatives as multi-kinase inhibitors with VEGFR-2 selectivity
by: AbdulAziz A. Alotaibi, et al.
Published: (2023-09-01)